• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[根治性前列腺切除术作为初诊时患有前列腺癌和骨转移患者多模式治疗理念的一部分]

[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].

作者信息

Spek A, Herlemann A, Gratzke C, Stief C G

机构信息

Urologische Klinik des Klinikums der Universität München, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.

出版信息

Urologe A. 2017 May;56(5):595-598. doi: 10.1007/s00120-017-0366-8.

DOI:10.1007/s00120-017-0366-8
PMID:28314969
Abstract

In patients with metastatic prostate cancer presenting with synchronous bone metastases, the surgical removal of the primary is an experimental treatment approach. In the following article, we evaluate the rationale for this approach.

摘要

在出现同步骨转移的转移性前列腺癌患者中，手术切除原发灶是一种实验性治疗方法。在接下来的文章中，我们评估这种方法的基本原理。

相似文献

1
[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].[根治性前列腺切除术作为初诊时患有前列腺癌和骨转移患者多模式治疗理念的一部分]
Urologe A. 2017 May;56(5):595-598. doi: 10.1007/s00120-017-0366-8.
2
[When is surgical resection of the primary tumor indicated in metastatic prostate cancer and what is the scientific rationale?].[转移性前列腺癌何时适合进行原发肿瘤的手术切除，其科学依据是什么？]
Urologe A. 2017 May;56(5):591-594. doi: 10.1007/s00120-017-0359-7.
3
[Cytoreductive, radical prostatectomy in metastatic prostate cancer].[转移性前列腺癌的细胞减灭性根治性前列腺切除术]
Urologe A. 2017 Nov;56(11):1430-1434. doi: 10.1007/s00120-017-0505-2.
4
Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?转移性前列腺癌的细胞减灭性根治性前列腺切除术：真的有意义吗？
World J Urol. 2017 Apr;35(4):567-577. doi: 10.1007/s00345-016-1906-3. Epub 2016 Aug 8.
5
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.根治性前列腺切除术后前列腺特异性抗原持续存在是临床无复发生存和总生存的预测因素：ARO 96-02 试验的 10 年数据。
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):288-94. doi: 10.1016/j.ijrobp.2014.09.039. Epub 2014 Nov 20.
6
[When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?].[转移性前列腺癌何时适合手术治疗，其科学依据是什么？]
Urologe A. 2017 May;56(5):599-603. doi: 10.1007/s00120-017-0361-0.
7
[When is a nonsurgical approach possible for metastatic primary tumors and lymph node metastases of the urinary bladder and prostate?].[对于膀胱和前列腺的转移性原发性肿瘤及淋巴结转移，何时可采用非手术方法？]
Urologe A. 2017 May;56(5):570-578. doi: 10.1007/s00120-017-0379-3.
8
[Surgical treatment of metastatic penile cancer - what is the scientific rationale?].[转移性阴茎癌的外科治疗——科学依据是什么？]
Urologe A. 2017 May;56(5):624-626. doi: 10.1007/s00120-017-0358-8.
9
[No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression].[对于前列腺切除术后无症状生化复发的前列腺癌患者，加用雄激素抑制进行挽救性放疗未显示能改善预后]
Strahlenther Onkol. 2017 Jan;193(1):86-88. doi: 10.1007/s00066-016-1082-9.
10
Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.前列腺癌合并少量骨转移患者的减瘤性根治性前列腺切除术：一项可行性及病例对照研究的结果
J Urol. 2015 Mar;193(3):832-8. doi: 10.1016/j.juro.2014.09.089. Epub 2014 Sep 22.

引用本文的文献

1
[Cytoreductive, radical prostatectomy in metastatic prostate cancer].[转移性前列腺癌的细胞减灭性根治性前列腺切除术]
Urologe A. 2017 Nov;56(11):1430-1434. doi: 10.1007/s00120-017-0505-2.

本文引用的文献

1
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.EAU-ESTRO-SIOG 前列腺癌诊治指南。第二部分：复发、转移和去势抵抗性前列腺癌的治疗。
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
2
[Active surveillance for low-risk prostate cancer].[低风险前列腺癌的主动监测]
Urologe A. 2016 Feb;55(2):269-81. doi: 10.1007/s00120-015-0025-x.
3
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
多西他赛、唑来膦酸或两者联合添加至前列腺癌一线长期激素治疗（STAMPEDE）：一项适应性、多组、多阶段、平台随机对照试验的生存结果
Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.
4
Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013-4.作者回复：关于朱莉娅·韦尔内、卢克·洪索姆、罗杰·科克尔伯格、杰姆·拉什巴斯。改善前列腺癌治疗结果：挖掘癌症登记处的信息宝库。《欧洲泌尿外科杂志》2016年；69卷：1013 - 1014页。
Eur Urol. 2016 Jun;69(6):1015. doi: 10.1016/j.eururo.2015.09.036. Epub 2015 Oct 9.
5
Prostate Cancer Registries: Current Status and Future Directions.前列腺癌登记处：现状与未来方向。
Eur Urol. 2016 Jun;69(6):998-1012. doi: 10.1016/j.eururo.2015.05.046. Epub 2015 Jun 6.
6
Final pathohistology after radical prostatectomy in patients eligible for active surveillance (AS).适合主动监测（AS）的患者在根治性前列腺切除术后的最终病理检查结果。
World J Urol. 2015 Jul;33(7):917-22. doi: 10.1007/s00345-015-1604-6. Epub 2015 Jun 6.
7
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.106 例初诊时远处转移性前列腺癌行根治性前列腺切除术的围手术期结局的多机构分析。
Eur Urol. 2016 May;69(5):788-94. doi: 10.1016/j.eururo.2015.05.023. Epub 2015 May 30.
8
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.主动监测和聚焦治疗在低危和中危前列腺癌中的作用。
World J Urol. 2015 Jul;33(7):907-16. doi: 10.1007/s00345-015-1603-7. Epub 2015 Jun 3.
9
The evolutionary history of lethal metastatic prostate cancer.致死性转移性前列腺癌的进化史。
Nature. 2015 Apr 16;520(7547):353-357. doi: 10.1038/nature14347. Epub 2015 Apr 1.
10
EAU guidelines on renal cell carcinoma: 2014 update.EAU 指南：肾细胞癌. 2014 年更新版.
Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.